![](/img/cover-not-exists.png)
Phase II trial of anti-idiotypic p53 peptides (Pentrys) plus granulocyte-macrophage colony-stimulating factor in patients with hormone-refractory prostate cancer
Ian D DAVIS, Guy TONER, Adam BROAD, Louise M CAMPANO, Mark ROSENTHALVolume:
3
Year:
2007
Language:
english
Pages:
8
DOI:
10.1111/j.1743-7563.2007.00101.x
File:
PDF, 171 KB
english, 2007